Xiaoying Ma1,
Zijiang Sang1,
Qinghua Zhang2,
Wenbiao Ma1 
For correspondence:- Wenbiao Ma Email: MWBLJ@163.com
Accepted: 25 October 2021 Published: 30 June 2024
Citation: Ma X, Sang Z, Zhang Q, Ma W. Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN. Trop J Pharm Res 2024; 23(6):1039-1039 doi: 10.4314/tjpr.v23i6.15
View the article corrected
© 2024 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
In the earlier published article, it was not indicated that there were authors who contributed equally to the work on the first page. This information is now provided as follows:
Xiaoying Ma and Zijiang Sang contributed equally to this work
New citation: Ma X, Sang Z, Zhang Q, Ma W. Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN. Trop J Pharm Res 2021; 20(11):2267-2272 doi: 10.4314/tjpr.v20i11.5 Erratum: 2024; 23(6): 1039 doi: http://dx.doi.org/10.4314/ tjpr.v23i6.15
Earlier citation: Ma X, Sang Z, Zhang Q, Ma W. Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN. Trop J Pharm Res 2021; 20(11):2267-2272 doi: 10.4314/tjpr.v20i11.5
Archives
News Updates
Fulltext in PDF